Advanced Metastatic Breast Cancer

DrugDrug NameDrug Description
DB12015AlpelisibAlpelisib is indicated in combination with fulvestrant to treat postmenopausal women, and men, with advanced or metastatic breast cancer.[Label] This cancer must be hormone receptor (HR)-positive, human epidermal growth factor...
DrugDrug NamePhaseStatusCount
DB00947Fulvestrant1Active Not Recruiting1
DB11925Vistusertib1Active Not Recruiting1
DB01217Anastrozole3Active Not Recruiting1
DB00014Goserelin3Active Not Recruiting1
DB00014Goserelin3Completed1
DB01006Letrozole3Active Not Recruiting1
DB01006Letrozole3Completed1
DB11730Ribociclib3Active Not Recruiting1
DB11730Ribociclib3Completed1
DB00675Tamoxifen3Active Not Recruiting1